CTSS

cathepsin S, the group of Cathepsins

Basic information

Region (hg38): 1:150730079-150765957

Links

ENSG00000163131NCBI:1520OMIM:116845HGNC:2545Uniprot:P25774AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CTSS gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CTSS gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
missense
5
clinvar
2
clinvar
7
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
1
clinvar
1
Total 0 0 5 2 2

Variants in CTSS

This is a list of pathogenic ClinVar variants found in the CTSS region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-150747785-C-A Benign (Jul 07, 2018)777937
1-150750072-C-T not specified Uncertain significance (Nov 08, 2022)2225121
1-150750132-T-C not specified Uncertain significance (Sep 29, 2022)2314453
1-150751772-A-T Benign (Aug 06, 2018)731670
1-150751830-A-G not specified Uncertain significance (Dec 21, 2022)2338368
1-150751874-T-G not specified Uncertain significance (Aug 21, 2023)2620128
1-150755041-T-G not specified Uncertain significance (Jul 25, 2023)2613626
1-150755062-C-T not specified Likely benign (Jul 25, 2023)2613528
1-150764757-G-A not specified Likely benign (Jan 19, 2024)3078793

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CTSSprotein_codingprotein_codingENST00000368985 735762
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.3420.6581257380101257480.0000398
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.24961810.5310.000009062174
Missense in Polyphen3081.0250.37025953
Synonymous0.9865464.00.8430.00000319615
Loss of Function2.98417.40.2298.32e-7219

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00002890.0000289
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00007040.0000703
Middle Eastern0.000.00
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Thiol protease. Key protease responsible for the removal of the invariant chain from MHC class II molecules. The bond- specificity of this proteinase is in part similar to the specificities of cathepsin L.;
Pathway
Antigen processing and presentation - Homo sapiens (human);Phagosome - Homo sapiens (human);Lysosome - Homo sapiens (human);Tuberculosis - Homo sapiens (human);Apoptosis - Homo sapiens (human);Neutrophil degranulation;Assembly of collagen fibrils and other multimeric structures;Trafficking and processing of endosomal TLR;Toll-Like Receptors Cascades;Collagen formation;Extracellular matrix organization;MHC class II antigen presentation;Innate Immune System;Immune System;Adaptive Immune System;Endosomal/Vacuolar pathway;Antigen processing-Cross presentation;Class I MHC mediated antigen processing & presentation;Degradation of the extracellular matrix (Consensus)

Recessive Scores

pRec
0.312

Intolerance Scores

loftool
0.251
rvis_EVS
0.22
rvis_percentile_EVS
67.92

Haploinsufficiency Scores

pHI
0.581
hipred
Y
hipred_score
0.573
ghis
0.536

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.688

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumHigh
CancerHighMediumHigh

Mouse Genome Informatics

Gene name
Ctss
Phenotype
muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; digestive/alimentary phenotype; immune system phenotype; skeleton phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype;

Gene ontology

Biological process
toll-like receptor signaling pathway;adaptive immune response;proteolysis;immune response;response to acidic pH;protein processing;antigen processing and presentation;antigen processing and presentation of exogenous peptide antigen via MHC class II;extracellular matrix disassembly;collagen catabolic process;basement membrane disassembly;neutrophil degranulation;antigen processing and presentation of peptide antigen;proteolysis involved in cellular protein catabolic process;cellular response to thyroid hormone stimulus;positive regulation of cation channel activity
Cellular component
extracellular region;extracellular space;lysosome;endolysosome lumen;lysosomal lumen;intracellular membrane-bounded organelle;collagen-containing extracellular matrix;tertiary granule lumen;ficolin-1-rich granule lumen
Molecular function
fibronectin binding;cysteine-type endopeptidase activity;serine-type endopeptidase activity;collagen binding;laminin binding;proteoglycan binding